Researchers at the Ohio State University College of Medicine have begun a clinical trial investigating the use of focused ultrasound to control a specific type of epilepsy in adult patients.
Up to 10 patients with medication-refractory lobe focal onset epilepsy will be enrolled in this study, which is funded by the Focused Ultrasound Foundation. Patients will receive transcranial focused ultrasound therapy to ablate (or destroy) a specific part of the brain involved in epilepsy.
“We’re pursuing this clinical trial because we know there’s a large unmet clinical need. More than 20 million people worldwide live with uncontrollable seizures because no available treatment works for them,” said neurosurgeon Dr. Vibhor Krishna, who is leading the study at The Ohio State University Wexner Medical Center and Ohio State’s Neurological Institute. “Our goals are to test the safety of this procedure and study changes in seizure frequency in these patients.”
“This is an important step in the evolution of focused ultrasound as a mainstream therapy for disorders affecting the brain,” said Foundation Chairman Neal F. Kassell, MD. “Ultimately, the results of this study could lead to new, more effective therapies for certain patients with epilepsy.”
Patients who are interested in participating in this trial should contact Angela Emerson, MPH, at (614) 685-3141 or angela.emerson@osumc.edu.
There is a clinical trial ongoing at the University of Virginia for medication-refractory epilepsy with subcortical focal lesions. For more information, see the trial’s listing on clinicaltrials.gov or contact Stacy Thompson (434-982-4315 or SRC2H@hscmail.mcc.virginia.edu).
Another trial at the University of California Los Angeles is addressing medication-refractory epilepsy in patients with subcortical lesions. For more information, see the trial’s listing on clinicaltrials.gov or contact Alex Korb, PhD (323-510-7532 or alexkorb@ucla.edu)
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
